TD Asset Management’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.2M | Buy |
+819,882
| New | +$60.2M | 0.05% | 275 |
|
|
2022
Q4 | – | Sell |
-994,297
| Closed | -$25.4M | – | 1457 |
|
|
2022
Q3 | $25.4M | Buy |
994,297
+33,849
| +4% | +$864K | 0.03% | 370 |
|
|
2022
Q2 | $22.8M | Hold |
960,448
| – | – | 0.03% | 404 |
|
|
2022
Q1 | $21.6M | Sell |
960,448
-201,840
| -17% | -$4.55M | 0.02% | 458 |
|
|
2021
Q4 | $23M | Buy |
1,162,288
+254,667
| +28% | +$5.04M | 0.02% | 483 |
|
|
2021
Q3 | $17.9M | Hold |
907,621
| – | – | 0.02% | 498 |
|
|
2021
Q2 | $18.9M | Buy |
907,621
+737,825
| +435% | +$15.3M | 0.02% | 493 |
|
|
2021
Q1 | $4.04M | Buy |
+169,796
| New | +$4.04M | ﹤0.01% | 890 |
|